Reported Earnings • 23h
Full year 2026 earnings released: EPS: ₹0.81 (vs ₹2.11 in FY 2025) Full year 2026 results: EPS: ₹0.81 (down from ₹2.11 in FY 2025). Revenue: ₹258.2m (down 1.5% from FY 2025). Net income: ₹3.41m (down 62% from FY 2025). Profit margin: 1.3% (down from 3.4% in FY 2025). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has fallen by 35% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • May 19
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹22.30, the stock trades at a trailing P/E ratio of 20.8x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 71% over the past three years. Tillkännagivande • May 12
Rite Zone Chemcon India Limited to Report Second Half, 2026 Results on May 15, 2026 Rite Zone Chemcon India Limited announced that they will report second half, 2026 results on May 15, 2026 Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹21.25, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 69% over the past three years. Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹16.20, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 79% over the past three years. New Risk • Nov 17
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.9% Last year net profit margin: 4.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Market cap is less than US$10m (₹105.1m market cap, or US$1.19m). Minor Risks Profit margins are more than 30% lower than last year (1.9% net profit margin). Revenue is less than US$5m (₹237m revenue, or US$2.7m). Board Change • Nov 14
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive & Independent Director Harshada Patil was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Nov 13
Rite Zone Chemcon India Limited to Report First Half, 2026 Results on Nov 13, 2025 Rite Zone Chemcon India Limited announced that they will report first half, 2026 results on Nov 13, 2025 Tillkännagivande • Sep 04
Rite Zone Chemcon India Limited, Annual General Meeting, Sep 29, 2025 Rite Zone Chemcon India Limited, Annual General Meeting, Sep 29, 2025, at 11:00 Indian Standard Time. Location: jp north club house, near vinay nagar, off. kashimira road, mira road east, thane- 401107, thane India Board Change • Jul 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. Non-Executive & Independent Director Harshada Patil was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. New Risk • Jun 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (₹105.8m market cap, or US$1.24m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Revenue is less than US$5m (₹302m revenue, or US$3.5m). Valuation Update With 7 Day Price Move • Apr 04
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹22.85, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 47% over the past year. Valuation Update With 7 Day Price Move • Mar 17
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₹21.50, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 53% over the past year. Valuation Update With 7 Day Price Move • Feb 14
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹32.00, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 41% over the past year. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹52.25, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 35x in the Chemicals industry in India. Total loss to shareholders of 20% over the past year. Reported Earnings • Oct 01
Full year 2024 earnings released: EPS: ₹2.67 (vs ₹2.37 in FY 2023) Full year 2024 results: EPS: ₹2.67 (up from ₹2.37 in FY 2023). Revenue: ₹267.2m (up 19% from FY 2023). Net income: ₹11.3m (up 36% from FY 2023). Profit margin: 4.2% (up from 3.7% in FY 2023). The increase in margin was driven by higher revenue. Tillkännagivande • Sep 12
Rite Zone Chemcon India Limited, Annual General Meeting, Sep 28, 2024 Rite Zone Chemcon India Limited, Annual General Meeting, Sep 28, 2024, at 11:00 Indian Standard Time. Location: jp north club house, near vinay nagar, off. kashimira road, mira road east, thane- 401107, thane India New Risk • May 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (57% accrual ratio). Market cap is less than US$10m (₹194.8m market cap, or US$2.34m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Revenue is less than US$5m (₹229m revenue, or US$2.8m). Valuation Update With 7 Day Price Move • Apr 09
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹49.40, the stock trades at a trailing P/E ratio of 19.9x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 36% over the past year. Valuation Update With 7 Day Price Move • Nov 29
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹67.00, the stock trades at a trailing P/E ratio of 26.9x. Average trailing P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 26% over the past year. Valuation Update With 7 Day Price Move • Nov 13
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹70.90, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 28x in the Chemicals industry in India. Total loss to shareholders of 22% over the past year. New Risk • Nov 10
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.0% average weekly change). High level of non-cash earnings (59% accrual ratio). Market cap is less than US$10m (₹253.8m market cap, or US$3.05m). Minor Risk Revenue is less than US$5m (₹225m revenue, or US$2.7m). Board Change • Oct 31
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Additional Non-Executive & Independent Director Harshada Patil was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Sep 05
Rite Zone Chemcon India Limited, Annual General Meeting, Sep 28, 2023 Rite Zone Chemcon India Limited, Annual General Meeting, Sep 28, 2023, at 11:00 Indian Standard Time. Location: JP North Club House, Near Vinay Nagar, Off. Kashimira Road, Mira Bhayander Road, Mira Road East Thane Maharashtra India Agenda: To receive, consider and adopt the Audited Financial Statements for the financial year ended 31st March, 2023 and the Reports of Director's and Auditor's thereon; to appoint a Director in place of Mrs. Arti Bhavesh Bhandari, who retires by rotation, and being eligible, offers herself for re-appointment; and to consider the appointment of Ms. Harshada Rupesh Patil (DIN: 10302027) as a Non-executive Independent Director of the Company. New Risk • Aug 09
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended March 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2022 fiscal period end). High level of non-cash earnings (86% accrual ratio). Revenue is less than US$1m (₹49m revenue, or US$595k). Market cap is less than US$10m (₹275.0m market cap, or US$3.32m). Minor Risk Share price has been volatile over the past 3 months (8.8% average weekly change). 
